Skip to content

Lentiviral Manufacturing

Industry leading technologies and services

OXGENE's XLenti™ production system builds on our considerable expertise in cell line development and plasmid engineering. Based on our widely recognised SnapFast™ plasmid technology, our XLenti™ platform includes an optimised plasmid system that delivers improved yield, quality and safety, while our manufacture-ready suspension-mode lentiviral packaging and producer cell lines enable large scale lentiviral production. This system maximises process reproducibility and reduces manufacturing costs for clinical and commercial cell therapy manufacture.

We offer expert cloning and engineering services to customise and optimise plasmids for expression of your gene of interest. Our process development services optimise for pre-clinical lentiviral manufacture in our ISO:9001 accredited lab, and we manufacture up to 10L scale, before assisting technology transfer to your own facilities or CMO.

We know that as cell therapy pioneers, you need complete confidence in the performance of our technologies once they're transferred to your own facilities. That's why our scientists speak directly to yours, offering ongoing and comprehensive technical support.

Talk to our team about scalable, high quality, high titre lentiviral production.

Get in touch

We use cookies to give you the best experience of using this website. By continuing to use this site, you accept our use of cookies. Please read our Cookie Policy for more information.

Our single technology platform that fully connects our smart labs with our customer service proposition.

Login

Connex revolutionises DNA design, optimization and assembly by ensuring the highest levels of quality control, efficiency and project management available for any client.

OXGENE has fully integrated all its smart labs and robotic production processes within a single technology platform that allows real-time project updates for our customers.